ACTU
Actuate Therapeutics
$0.37
−$0.01 (−3.13%)Oct 29, 2026
Key metrics
The numbers that frame ACTU today
- Market cap
- $8.91M
- ROIC
- 470%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.35
- 52wk High
- $7.90
Growth
Revenue and earnings trend for ACTU
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ACTU
Is Actuate Therapeutics a good buy?
No. Actuate Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Actuate Therapeutics is selling at a very high price.
What is the market capitalization of ACTU?
Actuate Therapeutics's market capitalization is $8.91M.
What is the 52-week high for ACTU stock?
The 52-week high for Actuate Therapeutics is $7.90. The current close of $0.37 is 95.3% below that high.
What is the 52-week low for ACTU stock?
The 52-week low for Actuate Therapeutics is $0.35. The current close of $0.37 is 6% above that low.
Does ACTU stock pay dividends?
Actuate Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ACTU?
Actuate Therapeutics's Debt / Equity ratio is 0.